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Arx and Nkx2.2 compound deficiency redirects
pancreatic alpha- and beta-cell differentiation to
a somatostatin/ghrelin co-expressing cell lineage
Simon Kordowich1, Patrick Collombat2,3*†, Ahmed Mansouri1,4*† and Palle Serup5†
Abstract
Background: Nkx2.2 and Arx represent key transcription factors implicated in the specification of islet cell subtypes
during pancreas development. Mice deficient for Arx do not develop any alpha-cells whereas beta- and delta-cells
are found in considerably higher numbers. In Nkx2.2 mutant animals, alpha- and beta-cell development is severely
impaired whereas a ghrelin-expressing cell population is found augmented.
Notably, Arx transcription is clearly enhanced in Nkx2.2-deficient pancreata. Hence in order to precise the functional
link between both factors we performed a comparative analysis of Nkx2.2/Arx single- and double-mutants but also
of Pax6-deficient animals.
Results: We show that most of the ghrelin+ cells emerging in pancreata of Nkx2.2- and Pax6-deficient mice,
express the alpha-cell specifier Arx, but also additional beta-cell related genes. In Nkx2.2-deficient mice, Arx directly
co-localizes with iAPP, PC1/3 and Pdx1 suggesting an Nkx2.2-dependent control of Arx in committed beta-cells.
The combined loss of Nkx2.2 and Arx likewise results in the formation of a hyperplastic ghrelin+ cell population at
the expense of mature alpha- and beta-cells. Surprisingly, such Nkx2.2-/-Arx- ghrelin+ cells also express the
somatostatin hormone.
Conclusions: Our data indicate that Nkx2.2 acts by reinforcing the transcriptional networks initiated by Pax4 and
Arx in early committed beta- and alpha-cell, respectively. Our analysis also suggests that one of the coupled
functions of Nkx2.2 and Pax4 is to counteract Arx gene activity in early committed beta-cells.
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Background
The pancreas is comprised of acinar and duct cells (exo-
crine compartment), producing and transporting diges-
tive enzymes and bicarbonate, as well as endocrine cells,
which secrete hormones to the blood stream. The latter
are aggregated into scattered clusters of cells, termed
islets of Langerhans. These are typically composed of
five cell subtypes, including alpha-, beta-, delta-, epsilon-
and PP-cells that produce the hormones glucagon, insu-
lin, somatostatin, ghrelin, and pancreatic polypeptide
(PP), respectively. Insulin and glucagon are secreted co-
ordinately to control glucose homeostasis, whereas
somatostatin and PP regulate the secretion of other hor-
mones and of exocrine enzymes [1-5]. The hormone
ghrelin has been shown to possess orexigenic properties
and to play a role in glucose-stimulated insulin secretion
[6,7].
During pancreas development, the first wave of endo-
crine cell differentiation begins at embryonic day (E) 9
and results in the emergence of glucagon-producing
cells, followed by the appearance of few insulin-produ-
cing cells, often co-expressing glucagon [8-12]. Ghrelin-
expressing cells can be detected from E10.5 on [2,13].
Subsequently, the major wave of endocrine cell forma-
tion ("secondary transition”), initiates around E13 and
results in the emergence of numerous insulin-producing
beta-cells and glucagon-producing alpha-cells. Around
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E15, the first somatostatin-producing delta-cells emerge
[10] while, shortly before birth, PP-expressing PP-cells
differentiate. Concurrently, from E14 on, the endocrine
cell mass continuously expands and self-organizes into
well-shaped islets, a process lasting until approximately
4 weeks postpartum [14].
A number of transcriptional regulators have been
shown to have crucial roles in controlling the specifica-
tion of pancreatic cells. Among these, Pdx1 was found
to exert a key function for the pancreatic cell lineage
allocation. Later during pancreatic development, Pdx1
activity is restricted to beta-cells and a subpopulation of
delta-cells [9,15-17]. The expression of the basic helix-
loop-helix transcription factor Ngn3 induces endocrine
differentiation, as evidenced by gain- and loss-of-func-
tion studies as well as genetic lineage tracing [18-21].
The specification towards the distinct endocrine cell
types was found controlled by the concerted activities of
specific transcription factors, including the homedo-
main-containing factors Nkx2.2 [22], Nkx6.1 [23], Pax6
[24], Brn4 [25], Pax4 [26] and Arx [27].
Nkx2.2 is broadly expressed in the early undifferen-
tiated pancreatic epithelium and in endocrine progeni-
tors. Along with the secondary transition, Nkx2.2
expression becomes restricted to mature beta-cells and a
subset of alpha- and PP-cells, whereas it is not detected
in delta-cells (reviewed in [28]). Accordingly, mice
depleted in Nkx2.2 display a complete beta-cell loss and
reduced alpha- and PP-cell content, while the numbers
of delta-cells remain unchanged. Notably, the ghrelin+
cell population appears considerably augmented [13,22].
In this context, it has been shown that Nkx2.2 is deci-
sive for the maintenance of normal beta-cell function
and that the transcriptional repressor activity of Nkx2.2
is required for the proper specification of alpha-cells
[29,30]. Nkx6.1 has been found essential for the specifi-
cation of multipotent progenitors towards the duct-/
endocrine-fates in early pancreas development [31]. Post
second transition, Nkx6.1 becomes exclusively restricted
to developing beta-cells; at that stage it is essential for
their expansion [23]. The Pax gene family member,
Pax6, is produced in all endocrine cells throughout pan-
creas development with one exception that is a subpo-
pulation of epsilon-cells [13,24]. Thus, in the absence of
functional Pax6, alpha-, beta-, delta- and PP-cells are
negatively affected with a near complete loss of gluca-
gon-expression from alpha-cells [24,25,32]. Similar to
Nkx2.2 mutants, the endocrine portion in Pax6-/- pan-
creata mainly consists of cells expressing the ghrelin-
hormone [2]. Pax4, another Pax family member, has
been found essential for the formation of beta- and
delta-cells [26,33]. Lineage tracing studies revealed that
Pax4+ precursor cells give rise to all four major endo-
crine cell types (beta-, alpha-, delta- and PP-cells) [34].
Nevertheless, in the absence of Pax4, beta- and delta-
cell development is impaired and precursor cells acquire
an alpha-cell-like fate, suggesting a predominant role of
Pax4 in the differentiation of beta-cells [26,27]. This
assumption is supported by recent work demonstrating
that the in vivo misexpression of Pax4 in pancreatic/
endocrine progenitors results mainly in the formation of
beta-cells. Moreover, the forced and ectopic expression
of Pax4 in mature alpha-cells was found sufficient to
convert these into functional beta-like cells [35].
Mice lacking the aristaless homeobox gene Arx display
a phenotype opposite to the one observed in Pax4-/- ani-
mals [27]. Depleted in alpha-cells, such mice exhibit
proportionally enlarged beta- and delta-cell populations.
In fact, a direct and mutually antagonistic transcrip-
tional repression between Arx and Pax4 was previously
demonstrated and associated with the specification of
the alpha- vs. beta-/delta-cell fates, respectively [36].
This model was further supported by the forced expres-
sion of Arx in pancreatic/endocrine progenitors, which
led to the favouring of the alpha- but also PP-cell fate,
at the expense of beta- and delta-cell lineages [37].
Interestingly, recent analyses of Nkx2.2-deficient pan-
creata outlined a 5-fold increase in the transcript con-
tent of the alpha-cell “specifier” Arx despite an almost
complete loss in glucagon-expressing cells [38]. To
address this apparent paradox, we undertook a thorough
comparative analysis of the endocrine populations aris-
ing in pancreata of wild type, Nkx2.2- and Pax6-defi-
cient animals. Moreover, we further analysed the roles
of Nkx2.2 and Arx, by characterizing pancreatic endo-
crine cell fates in mice compound-deficient for Nkx2.2
and Arx.
Results
Expression of Arx and Brn4 in E16.5 pancreata of wild
type, Nkx2.2-/- and Pax6-/- mice
We previously investigated the antagonistic roles of Arx
and Pax4 for proper endocrine cell allocation and
thereby demonstrated the essential function of Arx in
promoting a subset of endocrine precursor cells specifi-
cally towards the alpha-cell fate [27,36,37]. The apparent
discrepancy between the severely reduced alpha-cell
numbers and the 5-fold augmentation in Arx transcripts
upon loss of Nkx2.2, prompted us to examine the sub-
cellular localization of Arx in pancreata of such mice
and thus gain further insights into the role of Arx and
Nkx2.2 during endocrine cell specification.
We initially focused our study at E16.5, a developmental
stage subsequent to a peak in mature endocrine cell gen-
eration. In wild type pancreata, most Arx-labelled cells co-
expressed glucagon and were found scattered within the
pancreatic tissue (Figure 1A). Only few Arx+/glucagon-
cells were detectable, most likely corresponding to alpha-
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Figure 1 Expression of Arx and Brn4 in E16.5 pancreata of wild type, Nkx2.2-/- and Pax6-/- mice. (A, B) Arx is expressed in wild type
glucagon+ cells. (A, inset) Moreover, Arx+/glucagon- cells are detectable at this stage. (B, C, inset) Arx or Brn4 can be detected in a subset of
ghrelin+ cells. (D, inset) In Nkx2.2-mutant pancreata some of the remaining glucagon+ cells do not express Arx. (E, inset, F) Most Nkx2.2-deficient
ghrelin+ cells express Arx but only rarely Brn4. (G, H) Arx is expressed in pancreata of Pax6-/- mice and co-localizes with most ghrelin+ cells.
Scattered Arx+/ghrelin- and ghrelin+/Arx- cells can be detected. (I, inset) Brn4 is expressed in a subset of ghrelin+ cells and labels a ghrelin- cell
population in Pax6-deficient mice. Counterstaining with DAPI. (J-L) The percentages of Arx+/glucagon+, Arx+/ghrelin+ and Brn4+/ghrelin+ cells in
pancreata of wild type (WT), Nkx2.2-/- (N2.2) and Pax6-/- (P6) mice within the total glucagon+ and ghrelin+ cell populations, respectively, are
depicted. (M) Quantitative RT-PCR of Arx, Pax6 and Nkx2.2 mRNA in wild type, Nkx2.2-/-, Pax6-/- and Arx- E16.5 pancreas. (N) Quantification of Arx+
cells at E16.5 in pancreata of wild type, Nkx2.2-/- and Pax6-/- mice (n = 3 pancreas per genotype). Single-factor ANOVA coupled to Newman-Keuls
test was applied and p-values < 0,05 were assessed as statistically significant compared to wild type. Statistical significance is achieved with the
assumption of a normal distribution. Error bars represent SEM. (original magnification: 400×, Insets magnification: 4×).
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cell precursors that have not yet initiated hormone synth-
esis. Arx+ cells did not express ghrelin, except in rare
instances (Figure 1B). Interestingly, in Nkx2.2-deficient
animals, an almost complete lack of alpha- and beta-cells
accompanied by a five-fold increase in Arx transcript levels
were noted when compared to their control counterparts
([38], Figure 1M). Subsequent quantifications revealed a
2.4-fold rise in the numbers of Arx-immunoreactive cells
in E16.5 mutant pancreata compared to age-matched wild
type embryos (Figure 1D, N). Clearly, this number did not
fully reflect the upregulation of Arx transcripts, suggesting
an increase in Arx production at the single cell level.
These results led us to determine whether Nkx2.2 expres-
sion could be likewise affected in animals deficient for
Arx. However, Nkx2.2 transcript levels in E16.5 Arx
mutant pancreata were not significantly different from
wild type controls, suggesting that Nkx2.2 transcription is
not regulated by Arx (Figure 1M).
Further analyses of the Arx+ cell population in
Nkx2.2-/- mice revealed that a vast majority expressed
ghrelin. Approximately 90% of the ghrelin+ cells were
found positive for Arx (Figure 1E, K). Besides this ghrelin
+/Arx+ population, only few scattered Arx+/ghrelin- or
ghrelin+/Arx- cells were detectable in this genotype. Sur-
prisingly, most of the few remaining glucagon-expressing
cells present in Nkx2.2-deficient pancreata were negative
for Arx expression (Figure 1D inset, J). In order to further
assess the identity of ghrelin+/Arx+ cells, we analysed the
expression of the alpha-cell-related marker gene Brn4.
Previous analyses of Nkx2.2 mutant pancreata had
revealed that the numbers of Brn4+ cells were reduced;
correlating with the lower number of glucagon+ cells
[23]. Consistent with these findings, the expression of
Brn4 was absent from the hyperplastic ghrelin+ cells
noted in this genotype (Figure 1F, L). Altogether, these
results suggest that, in the absence of Nkx2.2, the beta-
and alpha-cell lineages are disfavoured and replaced by a
ghrelin+/Arx+/Brn4- cell fate. Considering the crucial
role exerted by Arx in promoting the alpha-cell lineage,
it is conceivable that such cells correspond to alpha-cell
precursors that failed to acquire the full complement of
alpha-cell characteristics. However, the observation that
the proportion of ghrelin+/Arx+/Brn4- cells present in
Nkx2.2-/- pancreata is similar to the proportion of beta-
cells normally detected in wild-type mice led us to favour
an alternative explanation where cells normally fated
towards the beta-cell lineage fail to properly differentiate
and ectopically express Arx and ghrelin.
The dramatic increase in Arx transcripts, combined
with the profound loss in Pax6 expression in Nkx2.2-
deficient pancreata (Figure 1M, [13,39]), prompted us to
get more insights into putative interplay between these
three factors. In Pax6 knockout mice [24,32], the early
glucagon+ population emerging around embryonic day
10.5 is present and properly express the associated mar-
kers Brn4 and Isl1 [25]. However, post secondary transi-
tion, glucagon+ cell numbers are significantly reduced
(Figure 1G, [24,25]). Consistent with these findings, it
was shown that Pax6, both indirectly and directly,
potentiates the expression of the glucagon gene
[32,40,41]. Interestingly, upon Pax6 deficiency, the beta-
cell population was found reduced concomitantly with a
5.6-fold increase in the numbers of ghrelin+ cells [2,24].
Notably, both Nkx2.2 transcript content and expression
pattern were found almost normal in Pax6-/- pancreata
as compared to their wild-type counterparts (Figure 1M,
[25]). Surprisingly, in E16.5 Pax6 mutant pancreata, Arx
transcripts were found 2.9 times increased as compared
to age-matched wild-type pancreata. However, the num-
bers of Arx+ cells were not significantly different from
those observed in wild type, indicating that the defi-
ciency in Nkx2.2 or Pax6 leads to a similar increase in
Arx transcripts at the single cell level (Figure 1M, N).
Interestingly, and similar to what we observed in
Nkx2.2-deficient mice, most of the Arx+ cells present in
Pax6-deficient pancreata, express ghrelin (Figure 1H,
inset). Approximately 80% of the ghrelin+ cells were
found to express Arx, although scattered Arx+/ghrelin-
and ghrelin+/Arx- cells were also detectable (Figure 1K).
The expression of Brn4 appeared unchanged in Pax6-
deficient mice at E14.5 and E16.5 ([25] and Figure 1I,
respectively). Brn4 expression was clearly noted in
approximately 45% of the ghrelin-expressing cells, sug-
gesting at least a partially overlapping expression with
Arx (Figure 1L). Notably, beside the ghrelin+/Brn4+ cell
population, Brn4+ cells were also found outside of the
ghrelin-stained areas (Figure 1I). Together, our data
indicate that the reduction of alpha- and beta-cell num-
bers in Nkx2.2-/- or Pax6-/- pancreata is accompanied by
an increase in the numbers of cells co-expressing Arx
and ghrelin. Interestingly, the loss of Arx does not seem
to impact on Nkx2.2 or Pax6 expression.
Comparative analysis of ghrelin+ cells in pancreata of
wild type, Nkx2.2-/- and Pax6-/- mice
To further assess the identity of the ghrelin+/Arx+ cell
population arising in pancreata of Nkx2.2-/- and Pax6-/-
mice, we assayed the expression of a number of beta-
cell-related markers, such as insulin, iAPP, PC1/3 and
Pdx1 at E17.5 (Figure 2). Most of these proteins have
previously been found expressed in both mutant pan-
creata, however their expression relative to ghrelin has
not been fully resolved [2,13,42].
Previous detailed analyses of wild type ghrelin-expres-
sing cells had led to the conclusion that these could be
subdivided into glucagon+ghrelin+ alpha-cells and gluca-
gon-ghrelin+ epsilon-cells. It should be noted that only a
subset of alpha-cells were actually found positive for
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ghrelin, such cells retaining glucagon, Arx and Brn4
expression (Figure 1B, C, [2,13]). For technical reasons, we
did not distinguish between these two populations in our
analysis of wild type pancreata. Notably, none of the wild
type ghrelin+ cells did express insulin, PC1/3, or Pdx1
(Figure 2A, C, D). However, approximately 20% of ghrelin
+ cells expressed iAPP at E17.5 (Figure 2B Arrow, N).
Next, we analysed the distribution of these markers
within the hyperplastic ghrelin+ population found in
Nkx2.2-deficient pancreata. Notably, Pdx1 expression
Figure 2 Co-detection of ghrelin and insulin, iAPP, PC1/3 or Pdx1 in pancreata of wild type, Nkx2.2-/- and Pax6-/- mice at E17.5. (A-D)
Wild type ghrelin+ cells do not express insulin, PC1/3 or Pdx1. However, scattered ghrelin+ cells express iAPP (Arrow). (E-H) No insulin reactive
cells are detectable in Nkx2.2-deficient pancreata. The majority of ghrelin+ cells express iAPP and low levels of Pdx1. Scattered iAPP+/ghrelin- (F)
and Pdx1+/ghrelin- cells (H, Arrows) are detectable. (G) PC1/3 is associated with a subpopulation of ghrelin-expressing cells in Nkx2.2-deficient
pancreata. (I-L) In pancreata deficient for Pax6 the population of ghrelin+ cells does not express insulin or iAPP except in very rare instances
(Arrows in I+J). Almost all Pax6-deficient ghrelin+ cells express PC1/3 but none produce Pdx1. Counterstaining with DAPI. (M-P) The percentages
of insulin+/ghrelin+, iAPP+/ghrelin+, PC1/3+/ghrelin+ and Pdx1+/ghrelin+ cells in wild type (WT), Nkx2.2-/- (N2.2) and Pax6-/- (P6) mice within the
total ghrelin+ cell population are depicted. Pictures were taken using confocal microscopy.
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had been detected in these cells, although at markedly
lower levels compared to wild type pancreata [22]. Our
analysis revealed, that approximately 80% of ghrelin-
expressing cells expressed low levels of Pdx1 (Pdx1low)
and iAPP in this genotype (Figure 2H, P). Moreover, we
frequently detected Pdx1+/ghrelin- cells close to hor-
mone-producing cells in the pancreatic epithelium of
such animals (Figure 2H, Arrows). The prohormone
convertase 1/3 was found localized in approximately
54% of ghrelin+ cells (Figure 2G, O). Thus, the majority
of the ghrelin+/Arx+ cells that emerge upon Nkx2.2 defi-
ciency significantly differ from wild type ghrelin+ cells.
The direct association of these beta-cell markers with
ghrelin+, and hence with Arx+ cells, provides a strong
evidence that at least a subpopulation of the ghrelin
+/Arx+ cells exhibit committed beta-cell characteristics,
and do not consist of putative alpha-cell precursors.
Interestingly, similar analyses of the ghrelin+/Arx+
population in Pax6-deficient pancreata outlined different
alterations. Notably, a few apparently normal beta-cells
develop in the absence of Pax6, these expressing insulin,
Pdx1, Hb9, Nkx6.1 and MafA [2,42]. However, we did
not detect co-expression of ghrelin and insulin, except in
very rare instances (Figure 2I Arrow, M). At comparably
low frequencies were detected iAPP+/ghrelin+ co-expres-
sing cells, however, the bulk of ghrelin+ cells appeared
negative for iAPP (Figure 2J, N). Moreover, and in con-
trast to the ghrelin+ population noted in Nkx2.2-deficient
pancreata, we did not observe any co-expression of ghre-
lin and Pdx1 in pancreata of such mice (Figure 2L, [2]).
Surprisingly, almost all ghrelin+ cells were immunoreac-
tive for PC1/3 (Figure 2K, O). Consequently, our data
reveal significant differences in the expression profile of
ghrelin+ cells arising in pancreata of Nkx2.2-/- and Pax6-/-
mice. While most ghrelin+ cells from Nkx2.2-deficient
embryos are positive for iAPP and Pdx1low, the majority
of the Pax6-/- ghrelin-cells do not express these markers.
Importantly, the expression of iAPP and Pdx1 is not per
se impeded upon Pax6 deficiency as it can clearly be
detected outside of the ghrelin-stained areas, probably
labelling the remaining beta-cells. Hence, our data sup-
ports the notion that, upon the loss of Nkx2.2 or Pax6
functional alleles, endocrine precursor cells are still com-
mitted towards the beta-cell lineage, do initiate the
expression of some beta-cell-specific determinants, but
fail to reach a mature beta-cell state and rather misex-
press Arx and ghrelin.
Next we assayed the expression of Pdx1, iAPP and
PC1/3 in relation with Arx in Nkx2.2-/- pancreata. Arx+
cells do not express Pdx1 or PC1/3 in wild type pan-
creata at E17.5 (Figure 3A, C). Scattered Arx+ cells co-
express iAPP at this age; however the bulk does not
(Figure 3B, inset). In contrast, the majority of the Arx+
cells arising in Nkx2.2-/- pancreata do co-express
Pdx1low, iAPP or PC1/3 (Figure 3D, Arrows, E, F).
Nkx2.2
-/-
Arx
- mice pancreata lack alpha- and mature beta-
cells and exhibit a hyperplastic ghrelin/somatostatin co-
positive cell population
Our results pointing towards a putative failure of beta-
cell development upon Nkx2.2 deficiency, prompted us
to investigate the role of Arx in this context. Specifically,
we asked (1) whether the loss of Nkx2.2 is directly
responsible for this failure or (2) whether the subse-
quent increase in Arx expression, resulting from Nkx2.2
deficiency, could lead to such phenotypic alteration. To
address this issue and gain further insight into the
mutual roles of Nkx2.2 and Arx in the processes under-
lying the specification towards the alpha- and beta-cell
lineages, we generated animals doubly mutant for
Nkx2.2 and Arx.
Double mutant mice were born following normal Men-
delian inheritance, indicating no embryonic lethality. In
contrast to their Nkx2.2- and Arx-single mutant litter-
mates surviving until postnatal day (P) 5 and 2, respec-
tively, compound animals did not suckle and died within
few hours postpartum. Analyses of their blood glucose
levels indicated a hypoglycaemic condition with blood
glucose levels lower than 20 mg/dl. Using immunofluor-
escence, we examined the different endocrine cell popu-
lations at P0 (Figure 4). Although Arx-single mutants
were found to exhibit a slight increase in the number of
beta-cells, we could not detect any insulin-immunoreac-
tive cells in compound mutant pancreata, further demon-
strating that functional Nkx2.2 is essential for the
formation of beta-cells (Figure 4A-D, [27]). As reported
in Arx-deficient pancreata, glucagon-immunoreactive
cells were lost in double-mutant mice (Figure 4F, H),
concurring with previous findings outlining Arx as an
alpha-cell lineage-defining factor [27,36,37]. PP-expres-
sing cells were detected in wild type, single- and double-
mutant mice although relatively rare in pancreata of
Nkx2.2-/- and Nkx2.2-/-Arx- newborns (Figure 4I-L).
Next, we assayed somatostatin-expressing delta-cells.
Wild type delta-cells classically do not express Nkx2.2.
Accordingly, they appeared in normal numbers in
Nkx2.2-deficient mice (Figure 4O, [22,23]). As previously
reported, the delta-cell population was found signifi-
cantly increased in Arx-mutants as compared to age-
matched controls (2.4-fold) (Figure 4N, [27]). Hence, we
expected an unopposed delta-cell differentiation in the
absence of both factors. Importantly, we noticed a dra-
matic increase in the number of somatostatin-producing
cells at all stages tested (E14.5, E18.5 and P0) as com-
pared to wild type, Arx- or Nkx2.2-deficent pancreata
(Figure 4M-P, data not shown).
Kordowich et al. BMC Developmental Biology 2011, 11:52
http://www.biomedcentral.com/1471-213X/11/52
Page 6 of 16
In P0 wild type pancreata, a small population of sin-
gle-hormone ghrelin+ epsilon-cells is detectable beside
glucagon+/ghrelin+ alpha-cells [2]. The loss of functional
Arx specifically depletes the population of glucagon
+/ghrelin+ alpha-cells but does not significantly impact
on the numbers of single-hormone ghrelin+ epsilon-cells
[2,27]. Similarly, glucagon+/ghrelin+ alpha-cells were
found lacking in pancreata of Nkx2.2-/- animals [13].
However, in the absence of both Nkx2.2 and Arx, a
drastic augmentation in ghrelin+ cells was observed,
such increase being similar to that of Nkx2.2-/- pan-
creata (Figure 4S, T). Surprisingly, somatostatin and
ghrelin co-detection revealed a great number of cells co-
expressing both hormones (Figure 4X, Y). This later
result was confirmed using two different sets of anti-
ghrelin and anti-somatostatin antibodies (Figure 4 and
data not shown). Notably, such bi-hormonal cells were
not detectable in P0 wild type, Nkx2.2- or Arx single
mutant mice (Figure 4U-W). Moreover, pancreata of
double heterozygous mice as well as of Nkx2.2-/-Arx+/-
or Nkx2.2+/-Arx- mice did not display such bi-hormonal
cells (data not shown).
We further quantified the different endocrine cell sub-
types present at P0 (Figure 4Y). In Nkx2.2-/- pancreata,
the numbers of ghrelin+ cells was found approximately
12 times increased compared to ghrelin+ cells in wild
type pancreata. Interestingly, a similar augmentation in
the total amount of ghrelin+ cells was noted comparing
pancreata of Nkx2.2 single and Nkx2.2/Arx double
mutants; however, approximately 80% of such ghrelin+
cells also expressed the somatostatin hormone in the
latter genotype. This suggests that Arx suppresses soma-
tostatin expression in Nkx2.2-/- ghrelin+ cells. It should
be noted that the numbers of single-hormone positive
somatostatin-producing cells observed in Nkx2.2-/-Arx-
were comparable to those of Nkx2.2-/- single knockout
and wild type pancreata. Equally important is the obser-
vation that the content of ghrelin+somatostatin+ cells
found in Nkx2.2-/-Arx- or of ghrelin+ noted in Nkx2.2-/-
were similar to the beta-cell numbers found in their
wild type counterparts. This finding further supports the
notion that beta-cells are correctly specified but fail to
properly differentiate in these genotypes. Altogether, our
findings demonstrate that the combined loss of Nkx2.2
and Arx prevents the formation of both insulin- and
glucagon-expressing endocrine cells, but has no effect
on the number of single-hormone positive somatostatin-
producing cells. However, an alternative cell subtype
develops, such cells expressing both ghrelin and soma-
tostatin hormones.
Nkx2.2/Arx-deficient endocrine cells express iAPP as well
as low levels of Pdx1 and Pax6
Pdx1 expression persists in developing and mature wild
type beta-cells and can be found in scattered delta-cells,
these two endocrine cell subtypes also expressing islet
Figure 3 Co-detection of Arx and Pdx1, iAPP or PC1/3 in pancreata of wild type and Nkx2.2-/- mice at E17.5. (A-C) Wild type Arx+ cells
do not express Pdx1 (A) or PC1/3 (C, inset). Most Arx+ cells do not express iAPP (B), except in rare instances (Arrowhead). (D-F) The majority of
Arx+ cells in Nkx2.2-/- pancreata express Pdx1low (Arrows), iAPP (E, inset) and PC1/3 (F, inset). Counterstaining with DAPI. Pictures were taken
using confocal microscopy (Insets magnification: 4×).
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Figure 4 Expression of endocrine hormones in pancreata of wild type, Arx-, Nkx2.2-/- and Nkx2.2-/-Arx- newborns. Insulin (A-D), glucagon
(E-H), pancreatic polypeptide (I-L), somatostatin (M-P) and ghrelin (Q-T) immunofluorescence-detection at P0. (D, H) Note that both beta- and
alpha-cells lack in Nkx2.2-/-Arx- double-mutant mice (original magnification: 200×). (U-X) Co-detection of ghrelin and somatostatin in P0 pancreata
of wild type, Arx-, Nkx2.2-/- and Nkx2.2-/-Arx- mice. Somatostatin+ cells and ghrelin+ cells label distinct cell populations in wild type (U), Arx- (V)
and Nkx2.2-deficient (W) pancreata. (X) However, in Nkx2.2-/-Arx- double mutant mice a population of ghrelin+/somatostatin+ co-positive cells is
detectable besides single-hormone-expressing ghrelin+ or somatostatin+ cells. Pictures in U-X were taken using confocal microscopy.
Counterstaining with DAPI. (Y) Quantification of hormone producing cells (without PP-cells) in pancreata of wild type, Arx-, Nkx2.2-/- and Nkx2.2-/-
Arx- mice at P0. Bars represent percentage of fluorescent cell area per total pancreatic area. n = 3 pancreas per genotype. Single-factor ANOVA
coupled to Newman-Keuls test was applied and p-values < 0,05 were assessed as statistically significant compared to wild type. Statistical
significance is achieved with the assumption of a normal distribution. Error bars represent SEM.
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amyloid polypeptide (IAPP) ([17,43-45] and Figure 5C).
Our observations prompted us to further characterize
the identity of the endocrine cells present in the pan-
creata of Nkx2.2-/-Arx- mice by investigating the expres-
sion of Pdx1 and iAPP in association with somatostatin
or ghrelin. Moreover, we also assessed the expression of
the endocrine marker Pax6 that had been suggested to
be Nkx2.2-dependent [13].
In contrast to the scattered expression of Pdx1 classi-
cally observed in delta-cells of wild type, Nkx2.2-/- or
Arx- embryos, Pdx1 could be detected in almost all
somatostatin+ cells present in Nkx2.2-/-Arx- double
mutant pancreata. Notably, Pdx1 expression levels were
markedly lower as compared to wild type pancreata but
comparable to the low Pdx1 levels found in Nkx2.2-/-
pancreata (Figure 5D, [39]). Furthermore, all somatosta-
tin+ cells were found to express iAPP (Figure 5F) and
low levels of Pax6 (Figure 5E). Subsequent analyses of
ghrelin-secreting cells in double mutant pancreata
expectedly revealed that a vast majority likewise
expressed these factors (Figure 5J-L). The expression of
these beta-cell associated genes can also be observed in
double-mutant pancreata at embryonic day 17 (Figure
5O, P). Hence, the alterations of Pdx1, iAPP and Pax6
expression appear similar in mice lacking Nkx2.2 and
animals deficient for both Nkx2.2 and Arx, outlining the
importance of Nkx2.2 in sustaining normal expression
levels of these genes. Consequently, the main endocrine
cell type found in pancreata of double mutant mice is
characterized by the expression of ghrelin, somatostatin,
Pdx1low, Pax6low and iAPP. Therefore, such cells display
the same beta-cell-like features as the ghrelin+ cells
found in Nkx2.2 single mutants and differ only in soma-
tostatin expression. Taken into account that, in Nkx2.2
single mutants, the population of ghrelin+/Pdx1low/iAPP
+ cells is also expressing high levels of Arx, it is concei-
vable that the loss of Arx promotes ectopic somatostatin
expression in such cells.
Expression of Pax4 and Nkx6.1 in pancreata of normal,
single- and double-mutant animals
To further determine the developmental stage at which
beta-cell differentiation is impaired in our mutant ani-
mals, we subsequently assayed the expression of the
endocrine precursor marker Pax4 (Figure 6, [26,34]).
Broadly expressed in the embryonic pancreas around
E16.5, its expression successively declines and is rarely
detectable in newborns [39]. However, low expression
levels have been noted in adult beta-cells [35]. More-
over, Pax4 has been shown to be essential for the forma-
tion of beta- and delta-cells, and for the expression of a
normal set of genes associated with beta-cell characteris-
tics. In accordance with previous studies detecting Pax4
transcripts in Arx- or Nkx2.2-deficient mice, we
observed numerous Pax4+ cells at embryonic day 16.5 in
the pancreatic epithelium of such animals using immu-
nohistochemical detection (Figure 6B, C). We have pre-
viously reported that the Arx factor binds the Pax4
promoter and negatively regulates Pax4 expression,
thereby specifying alpha vs. beta-cell fates [36,37]. How-
ever, despite markedly elevated Arx transcript levels
upon the loss of functional Nkx2.2, we did detect nor-
mal Pax4+ cell numbers in pancreata of E16.5 Nkx2.2-/-
mice, suggesting that, in this genotype and at this age,
Pax4 is not downregulated by Arx. Interestingly, the
combined loss of Nkx2.2 and Arx did not impact in the
number of Pax4+ cells as compared to Nkx2.2 mutant
pancreata, thus indicating that their formation does not
depend on either factor (Figure 6D, E). Notably, and in
agreement with previous findings, Pax4 expression was
not detectable in ghrelin+ cells of wild type or mutant
pancreata.
Next, we analysed the temporal expression of Nkx6.1
in pancreata of all four genotypes (Figure 7). Impor-
tantly, previous studies had shown that both Pax4 and
Nkx2.2 are essential to maintain the expression of
Nkx6.1 in developing beta-cells [23,39]; in the absence
of either factor, a decrease in Nkx6.1+ cell numbers was
seen from E16.5 on, progressing to a complete loss of
Nkx6.1+ cells in newborns. The loss of Arx had no
impact on Nkx6.1 expression as it was found maintained
and properly located in emerging beta-cells (Figure 7F,
[27]). In Nkx2.2-/-Arx- compound mutant mice, we
observed a temporal expression pattern of Nkx6.1 com-
parable to that of Nkx2.2-deficient pancreata; broadly
expressed in the undifferentiated pancreatic epithelium
at E15.5, the number of Nkx6.1+ cells was found drasti-
cally reduced at E18.5, while no Nkx6.1+ cells could be
detected at P0 (Figure 7C, D, G, H and data not shown).
Recent studies have demonstrated that Nkx6.1+ cells
arising during embryonic pancreatogenesis can be subdi-
vided into Sox9+ and Sox9- cells, representing ductal/
endocrine progenitors and committed beta-cells, respec-
tively [31,46,47]. In order to characterize the Nkx6.1+
population within the different genotypes, we co-
detected Nkx6.1 and Sox9 using immunofluorescence.
In E15.5 wild type and Arx-mutant pancreata, numerous
Nkx6.1+Sox9- beta-cells are detectable besides Nkx6.1
+Sox9+ progenitor cells (Figure 7I, J, M). Interestingly,
in Nkx2.2-deficient genotypes, Nkx6.1+ cells were found
associated to the uncommitted progenitor population
(Figure 7K, L, M). These data clearly demonstrate that
the expression of Nkx6.1 is not dependent on Nkx2.2
activities within Sox9+ progenitor cells. However, as
soon as a cell enters the endocrine lineage, Nkx6.1
expression is found highly dependent on Nkx2.2. These
results also imply that the steady decline in Nkx6.1+ cell
numbers observed in Nkx2.2-/- pancreata, most likely
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Figure 5 Expression of Pdx1, Pax6 and iAPP in pancreata of wild type and Nkx2.2-/-Arx- newborns. (A) In wild type pancreata, a
subpopulation of delta-cells expresses low levels of Pdx1 (Arrow) while the bulk does not. (B, C) Wild type delta-cells express Pax6 and iAPP. (D,
inset) Notably, in Nkx2.2-/-Arx- mice almost all somatostatin+ cells display low levels of Pdx1. (E, F, insets) Nkx2.2-/-Arx- somatostatin+ cells are
immunoreactive for iAPP and low levels of Pax6. (G) Wild type epsilon-cells do not express Pdx1. (H, I) Pax6 or iAPP can be detected in a subset
of wild type ghrelin+ cells (Arrows); a few ghrelin+ cells are negative for Pax6 or iAPP (Arrowheads). (J, K) In Nkx2.2-/-Arx- pancreata, the majority
of ghrelin+ cells are found positive for low levels of Pdx1 and Pax6; scattered ghrelin+ cells do not express Pax6 (K, Arrowhead). (L, inset) Islet
amyloid polypeptide is detectable in the majority of ghrelin+ cells; some are negative for iAPP (Arrowhead). Pictures in D, E, J and K have been
captured using a 2-fold exposure time compared to respective control images in order to allow for a clear detection of Pdx1 and Pax6 (original
magnification 800×). C, F, I and L are counterstained with DAPI. (M-N) Confocal images of E17.5 wild type and Nkx2.2/Arx double-mutant
pancreata. Similar to the expression patterns in newborns, Nkx2.2/Arx double-deficient ghrelin+ cells express somatostatin, Pdx1low and iAPP at
E17.5.
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reflects the normal decrease of progenitor cells classi-
cally noted in the last days of embryonic pancreas devel-
opment [47].
Taken together, our results demonstrate that Nkx2.2
and Arx are dispensable for the generation of Pax4+
cells. Moreover, the alterations in the expression of
Pdx1, Nkx6.1 and Pax6, appear similar when comparing
pancreata of Nkx2.2-single and Nkx2.2/Arx compound-
mutants, suggesting that the failure of beta-cell differen-
tiation and the associated ghrelin misexpression are
solely caused by the loss of Nkx2.2. Similarly, the dra-
matic alterations in alpha-cell development in Nkx2.2-/-
pancreata, where Arx expression is even more pro-
nounced, sustain the notion that Nkx2.2 is also neces-
sary for the acquisition of mature alpha-cell fate.
Discussion
In this study we have (re-) examined the consequences
of the loss-of-function of Pax6, Arx or Nkx2.2, as well
as of the combined loss of Nkx2.2 and Arx, on the
development of pancreatic endocrine hormone-produ-
cing cells. Previous studies had shown that the loss of
Nkx2.2 or Pax6 results in the formation of numerous
ghrelin-expressing cells at the expense of the beta- and
alpha-cell populations [2,13]. Herein, we demonstrate
that the majority of such ghrelin+ cells express the
alpha-cell specifier Arx. However, further expression
analyses focusing on ghrelin and alpha- or beta-cell-
related genes suggest a partial association of the mutant
ghrelin+/Arx+ population to the beta-cell lineage. The
combined loss of Nkx2.2- and Arx likewise results in the
formation of numerous ghrelin+ cells at the expense of
alpha- and beta- cells, whereas delta-cell formation
appears unaffected. Notably, the majority of the ghrelin+
cells were, yet again, found to display some of the fea-
tures classically associated to beta-cells, but also to ecto-
pically express somatostatin, suggesting that the
additional loss of Arx promotes the ectopic expression
of somatostatin.
Ghrelin+ cells arising in Nkx2.2-deficient pancreata display
different characteristics as compared to ghrelin+ cells
arising in wild type or Pax6-deficient mice
Previous reports have revealed that the loss of Pax4,
Nkx2.2 or Pax6 is accompanied by the emergence of
numerous ghrelin+ cells at the expense of the beta-cell
population [2,13,33]. Notably, in either mutant pancreas,
the expression of the two other genes is detectable, ren-
dering it difficult to attribute putative ghrelin-suppres-
sing activities to one of the three candidates. At least for
Pax4, such ghrelin-suppressing function has been
demonstrated in vitro, whereas Nkx2.2 has been shown
to exhibit ghrelin-activating functions in cell culture
experiments [33,48]. However, Pax4 expression remains
detectable in Nkx2.2- or Pax6-mutant pancreata, sug-
gesting that ghrelin-silencing requires multiple factors.
Interestingly, in all three mutants, Arx transcripts levels
are found increased and Arx is often associated with
ghrelin-expressing cell populations ([33,38], this study).
Figure 6 Pax4 expression in pancreata of wild type, Arx-,
Nkx2.2
-/- and Nkx2.2-/-/Arx- at E16.5. (A-D) Pax4-expressing cells
are present in normal numbers at E16.5 in pancreata of wild type,
Arx-, Nkx2.2-/- and Nkx2.2-/-/Arx- mice. Notably, no co-expression of
Pax4 and ghrelin is detectable in wild type or mutant pancreata.
Pictures were taken using confocal microscopy. (E) Quantification of
Pax4+ cells at E16.5 in pancreata of wild type, Arx-, Nkx2.2-/- and
Nkx2.2-/-Arx- mice (n = 3 pancreas per genotype). Single-factor
ANOVA coupled to Newman-Keuls test was applied and p-values <
0,05 were assessed as statistically significant compared to wild type.
Statistical significance is achieved with the assumption of a normal
distribution. Error bars represent SEM.
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The possibility that Arx acts as a putative ghrelin-activa-
tor, however, appears unlikely as ghrelin-expression is
also broadly maintained in cells arising in Nkx2.2/Arx
compound mutants.
In an effort to better characterize such mutant ghre-
lin-expressing cells, we analysed co-expression of ghrelin
and alpha-or beta-cell related markers in pancreata of
wild type, Pax6-/- and Nkx2.2-/- mice. The bulk of the
Nkx2.2-deficient ghrelin+ cells expresses Arx, iAPP,
PC1/3 and Pdx1 and thus strongly differs from wild
type epsilon-cells, excluding a specific augmentation of
epsilon-cell numbers upon Nkx2.2 depletion. As pre-
viously suggested, our data strengthens the notion, that
the majority of ghrelin+ cells arising in Nkx2.2-deficient
mice represent committed beta-cells that fail to properly
differentiate [22,23].
Wang et al. suggested that Nkx2.2 acts in synergy with
Pax4 during the early steps of beta-cell differentiation
Figure 7 Nkx6.1 expression is differentially dependent on Nkx2.2. (A-D) Nkx6.1 is broadly expressed in the pancreatic epithelium of wild
type, Arx-, Nkx2.2-/- and Nkx2.2-/-Arx- mice at embryonic day 15.5. (E, F) In wild type and Arx-mutants, Nkx6.1 expression is maintained and
detectable at P0. (G, H) However, in the absence of Nkx2.2 or Nkx2.2/Arx, a steady decrease in Nkx6.1+ cell numbers is detected from E15.5 on so
that Nkx6.1+ cells are not detectable in pancreata of newborns. No co-expression of Nkx6.1 and ghrelin is detectable in wild type or mutant
tissues at the investigated developmental time-points (original magnification 400×). (I-L) Nkx6.1+Sox9+ ductal/endocrine progenitors are present
in all four genotypes at E15.5. In wild type and Arx-mutants Nkx6.1+Sox9- cells are detected in comparable numbers. (K, L) However, in the
absence of Nkx2.2 or Nkx2.2 and Arx no such cells are detectable. Pictures in I-L were taken using confocal microscopy. (M) Quantification of
Nkx6.1+Sox9- cell numbers in E15.5 pancreata of wild type, Arx-, Nkx2.2-/- and Nkx2.2-/-Arx- mice (n = 3 pancreas per genotype). Single-factor
ANOVA coupled to Newman-Keuls test was applied and p-values < 0,05 were assessed as statistically significant compared to wild type.
Statistical significance is achieved with the assumption of a normal distribution. Error bars represent SEM.
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[39]. Interestingly, the population of ghrelin+/glucagon+
cells emerging in pancreata of Pax4-deficient mice share
many characteristics with the one observed in Nkx2.2-
deficient mice, including the expression of Arx, iAPP,
Pdx1low and PC1/3 ([33], data not shown). It is therefore
conceivable, that such cells likewise represent com-
mitted beta-cell precursors and that the presence of
Nkx2.2 and Arx allows their maturation towards a glu-
cagon-expressing state. Wang et al. also outlined that
synergistic activities of Nkx2.2 and Pax4 are essential in
the early steps of beta-cell differentiation in order to
activate crucial factors, such as Hb9, Nkx6.1 and
Pdx1high [39]. Furthermore, we previously demonstrated
that Pax4 strongly suppresses Arx expression in early
beta-cells [27,36]. Together with these findings, our cur-
rent data provides strong evidence for the essential
synergistic activity of Nkx2.2 and Pax4 to suppress Arx
expression in early committed beta-cells. A strict control
of Arx production appears essential as Arx is sufficient
to convert mature beta-cells into PP-like or alpha-like
cells [37]. The facts that Nkx2.2 is also expressed in
alpha-cells and that alpha-cell development is impaired
upon Nkx2.2 deficiency, lead to the assumption that the
lineage determining activities of both Arx and Pax4
require Nkx2.2 activity.
We also demonstrate that the lack of functional Pax6
results in the formation of ghrelin+/Arx+ cells. Pax6 was
thought to exert a more general role in the maintenance
of the beta-cell identity. The presence of a few but
apparently normal beta-cells in pancreata of Pax6-defi-
cient mice even led to the suggestion of an alternate
Pax6-independent pathway leading to mature beta-cells
[42]. Interestingly, we frequently detected scattered insu-
lin+/ghrelin+ cells in such mutant pancreata. Such cells
might represent a transitional state of beta-cells convert-
ing into ghrelin+ cells. Tracing the lineage of insulin-
expressing cells in the Pax6-deficient background would
doubtless shed more light on this interesting issue.
However, Pax6-deficient ghrelin+ cells express neither
iAPP nor Pdx1, thus differing from the ghrelin+ popula-
tions arising in Nkx2.2- or Pax4-deficient pancreata.
The presence of iAPP and Pdx1 in the remaining Pax6-
deficient beta-cells indicates that Pax6 is not necessary
for the activation of these genes. However, it is concei-
vable that Pax6 function is essential for maintaining
their expression as soon as a beta-cell reaches a certain
stage of differentiation.
The almost complete loss of glucagon+ cells in Pax6-
deficient mice indicates a more essential role of Pax6 in
alpha-cells. In this context, it has been demonstrated
that Pax6 binds and activates the glucagon gene
[32,40,41,49], however it remains unknown whether
Pax6 is also involved in the determination of the alpha-
cell lineage. The continued expression of three alpha-
cell related genes (Nkx2.2, Arx, Brn4) in Pax6-deficient
pancreata might be an indication for a predominant
involvement of Pax6 in later stages of alpha-cell
differentiation.
Ghrelin+/somatostatin+ cells arising in Nkx2.2/Arx
compound mutants represent a non-delta-cell type
Our analysis shows that the combined loss of Nkx2.2 and
Arx prevents the formation of mature alpha- and beta-
cells, thus confirming the requirement of Arx and Nkx2.2
activities for the formation of these cell types. However,
the presence of Pax4+ cells indicates that an endocrine
precursor state is attained without Nkx2.2 and/or Arx.
This, and previous studies, suggest that Nkx2.2 is essential
for the maintenance of high levels of Pdx1 and Pax6 as
well as the activation of Nkx6.1 in developing beta-cells
[13,22,39]. Consistent with these assumptions, the altera-
tions found in the expression of Pdx1, Pax6 and Nkx6.1
appear similar, comparing pancreata of Nkx2.2 single- and
Nkx2.2/Arx compound-mutant mice. These data once
more imply that Arx is dispensable for the beta-cell fate
and that the proper expression of these genes can be
attributed to Nkx2.2 alone.
However, the additional loss of Arx results in the for-
mation of numerous ghrelin+/somatostatin+ cells beside
populations of single-hormone positive somatostatin+ or
ghrelin+ cells. We did not detect ghrelin expression in
delta-cells arising in wild type or either single-knockout
pancreata. Together with the observation that neither
Nkx2.2 nor Arx is expressed in wild type delta-cells, we
conclude that such double positive cells do not repre-
sent delta-cells ectopically expressing ghrelin but rather
a population comparable to the ghrelin+ cells arising in
Nkx2.2-deficient mice. This is further supported by the
fact that ghrelin+/somatostatin+ cells display the same
broad expression of Pdx1low as observed in Nkx2.2-defi-
cient ghrelin+ cells. Hence, we conclude that 80% of the
ghrelin+ cells initiate somatostatin expression upon the
additional loss of Arx. Not all ghrelin-labelled cells co-
express somatostatin in double-mutant pancreata. This
might be attributed to their distinct predeterminations
and partially reflect the presence of normal epsilon-cells.
Nevertheless, our data also imply that Arx or a not yet
identified downstream mediator exerts a suppressive
effect on somatostatin expression. In this context, pre-
vious studies demonstrated that Arx activities strongly
antagonize delta-cell formation [27,36,37]. However,
whether Arx directly antagonizes somatostatin expres-
sion would require further investigations.
Conclusions
Our data indicate that although proper endocrine differ-
entiation/hormone expression is impaired in Pax6- or
Nkx2.2-deficient pancreata, committed cells retain some
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of the characteristics normally associated with mature
beta-cells (Figure 8). Our analysis of Nkx2.2/Arx single-
and double-mutant pancreata allow us, together with
the data from others, to conclude that both Pax4 and
Arx require the activity of Nkx2.2 in order to maintain
the transcriptional cascades initiated in early committed
beta- and alpha-cell precursors, respectively. Our find-
ings also suggest that one of the coupled functions of
Nkx2.2 and Pax4 is the control of Arx gene activity in
committed beta-cell precursors.
Methods
Animals
Mice heterozygous for both Nkx2.2 and Arx were gener-
ated by crossing Nkx2.2+/- males [22] with Arx+/-
females [27] and maintained in an NMRI background.
Double heterozygous females were further bred with
Nkx2.2+/- males. Moreover, we utilized tissue from
Pax6-nullizygous mice previously described by [24].
Genotyping was performed as described in [22,24,27].
Animal care and experimental use were approved by the
Ordnungsamt der Stadt Göttingen, Germany.
Immunohistochemistry
Pancreata were fixed 30 minutes in 4% paraformalde-
hyde at 4°C, dehydrated through graded alcohols and
embedded in paraffin. 8 μm (P0) or 5 um-sections
(E15.5-E17.5) were rehydrated and blocked in PBS con-
taining 10% inactivated fetal calf serum for 60 min. Pri-
mary antibodies were diluted in the same medium,
applied onto sections, and incubated overnight at 4°C.
Slides were washed in PBS and incubated for 45 min
with the appropriate secondary antibody diluted in PBS
containing 10% inactivated fetal calf serum. Slides were
washed in PBS, mounted with DAPI, and viewed by
fluorescent or confocal microscopy.
The primary antibodies used were as follows: rabbit
anti-Brn4 1/200 [kindly provided by A. Ryan (McGill
University, Montreal, QC)]; guinea-pig anti-insulin 1/
1000 (Dako); guinea-pig anti-insulin 1/1000 (Linco), gui-
nea-pig anti-glucagon 1/1000 (Linco); rabbit anti-soma-
tostatin 1/600 (Dako); rat anti-somatostatin 1/200
(Millipore); rabbit anti-PP diluted 1/200 (Linco); mouse
anti-ghrelin 1/1500 [kindly provided by C. Tomasetto
(Université Louis Pasteur, Strasbourg, France)]; goat
anti-ghrelin 1/50 (Santa Cruz), rabbit anti-ghrelin 1/
1000 (Millipore), rabbit anti-Amylin 1/300 (Phoenix
Pharmaceuticals); rabbit anti-Nkx6.1 diluted 1/3000;
rabbit anti-Pdx1 diluted 1/1000 [kindly provided by C.
Wright (Vanderbilt University, Nashville, TN)]; rabbit
anti-Pax6 1/1000 (Covance); rabbit anti-Pax4 1/1000
[kindly provided by B. Sosa-Pineda (St. Jude Children’s
Figure 8 Schematic representation of transcription factor combinations guiding beta-cell differentiation. Following the loss of Nkx2.2 or
Pax6, endocrine cells retain some beta-cell characteristics, such as the expression of iAPP, Pdx1 and/or PC1/3 (indicated as “b”). Rectangles
describe transcription factor combinations required to maintain the embryonic beta-cell differentiation program pre- and post-insulin expression
(light and dark green, respectively). Shortly after the activation of Ngn3, both Nkx2.2 and Pax4 are necessary for the expression of additional
beta-cell specific TF’s such as Nkx6.1 (not depicted). Concomitantly, this combination of TF’s prevents the misexpression of Arx and ghrelin in
committed beta-cells. In the absence of both Nkx2.2 and Arx, endocrine cells retain the same beta-cell features as noted in the absence of Nkx2.2
only, but then express ghrelin and somatostatin. Pax6 appears necessary for maintaining normal beta-cell identity at later stages of differentiation,
probably shortly after insulin activation. At that stage Pax6 presumably takes over some of the functions previously exerted by Pax4, whose
expression decreases.
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Research Hospital, Memphis, TN)], rabbit anti-PC1/3
diluted 1/500 (Millipore), rabbit anti-Arx diluted 1/250,
guinea-pig anti-Arx diluted 1/500 and rabbit anti-Sox9
1/200 (Millipore).
The secondary antibodies (invitrogen, dilution 1/1000)
used for immunofluorescence were as follows: 594-alexa
anti-mouse; 488-alexa anti-mouse, 594-alexa anti-rabbit;
488-alexa anti-rabbit; 594-alexa anti-guinea pig; 488-
alexa anti-guinea pig; 594-alexa anti-goat and 488-alexa
anti-goat. Images were taken using either a Leica TCS
confocal-laser scanning microscope or an Olympus
BX60 fluorescent microscope.
Morphometric Analyses
P0 pancreata from wild type, Arx-, Nkx2.2-/- and
Nkx2.2-/-Arx- mice were serially sectioned and every
twelfth section (10 sections per pancreas) was stained
for insulin, glucagon and ghrelin or somatostatin and
ghrelin. Non-overlapping pictures were taken from every
section using 10× magnification and same exposure
times. Total pancreatic area and fluorescent cell area
were determined using the histogram- and colour range
functions in Adobe Photoshop. Results are displayed as
fluorescent cell area per total pancreatic area. In order
to assess the numbers of Arx+, Pax4+ (at E16.5) or
Nkx6.1+Sox9- cells (at E15.5) pancreata were sectioned
(5 um) and every eighth section (6 sections per pan-
creas) was stained with the respective antibodies. The
numbers of Arx+, Pax4+ or Nkx6.1+Sox9- cells were
counted by microscopy and subsequently standardized
to the pancreatic area.
For both morphometric analysis a single-factor
ANOVA coupled to Newman-Keuls test was applied
and p-values < 0,05 were assessed as statistically signifi-
cant compared to wild type (n = 3 pancreata for each
genotype). Statistical significance is achieved with the
assumption of a normal distribution. In order to deter-
mine the percentages of copositive cells (Arx+/glucagon
+, Brn4+/ghrelin+, Arx+/ghrelin+, insulin+/ghrelin+, Pdx1
+/ghrelin+, iAPP+/ghrelin+ and PC1/3+/ghrelin+), 10
microscopy fields (per pancreas) of representative areas
were counted. Error bars represent SEM.
mRNA Quantification
Total RNA was isolated with the RNeasy Plus Mini Kit
(Qiagen) using whole pancreata at E16.5 (n = 3 per gen-
otype). 5 ug total RNA of each pancreas was subjected
to cDNA synthesis with the SuperScript II Reverse
Transcriptase Kit (invitrogen) following the manufac-
turer’s instructions. The amount of Arx (QT00162904),
Pax6 (QT01052786) and Nkx2.2 (QT00495502) tran-
scripts was assessed relative to Gusb (QT00176715)
using the QuantiTect SYBR Green PCR Kit from
Qiagen. Quantitative PCR’s were processed using the
eppendorf Mastercycler realplex system.
Glucose levels
Glucose levels were determined with the One Touch
Glucose monitoring kit (Johnson & Johnson) using 15 ul
of peripheral blood.
Acknowledgements and Fundings
We are most grateful to A. Ryan, C. Tomasetto, C. Wright and B. Sosa-Pineda
for providing antibodies. The authors are supported by the Max-Planck
Society, the Dr. H. Storz and Alte Leipziger foundation, the Juvenile Diabetes
Research Foundation, the European Research Council, the INSERM AVENIR
program, the INSERM, the Fondation pour la Recherche Médicale, the
Agence Nationale de la Recherche, the Schlumberger Foundation, the
Bundesministerium für Bildung und Forschung (BMBF: 01KU0906), Club Isatis,
Mr. and Mrs. Olivier Dorato, and the NIH Beta Cell Biology Consortium (DK
072495). We thank L. Sussel for Nkx2.2 mice.
Author details
1Department of Molecular Cell Biology, Max-Planck Institute for Biophysical
Chemistry, Am Fassberg, D-37077 Göttingen, Germany. 2Diabetes Genetics
team, Inserm U636, FR-06108 Nice, France. 3Université de Nice Sophia-
Antipolis, FR-06108 Nice, France. 4Department of Clinical Neurophysiology,
University of Göttingen, Robert-Koch Strasse 40, D-37075 Göttingen,
Germany. 5Department of Developmental Biology, Hagedorn Research
Institute, Niels Steensensvej 6, DK-2820 Gentofte, Denmark.
Authors’ contributions
SK designed the study, carried out all experiments, and wrote the
manuscript. PC, AM and PS conceived the study, and participated in its
design and coordination and helped to draft and write the manuscript. All
authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 6 May 2011 Accepted: 31 August 2011
Published: 31 August 2011
References
1. Adrian TE, Bloom SR, Hermansen K, Iversen J: Pancreatic polypeptide,
glucagon and insulin secretion from the isolated perfused canine
pancreas. Diabetologia 1978, 14:413-7.
2. Heller RS, Jenny M, Collombat P, Mansouri A, Tomasetto C, Madsen OD,
Mellitzer G, Gradwohl G, Serup P: Genetic determinants of pancreatic
epsilon-cell development. Dev Biol 2005, 286:217-24.
3. Korbonits M, Goldstone AP, Gueorguiev M, Grossman AB: Ghrelin–a
hormone with multiple functions. Front Neuroendocrinol 2004, 25:27-68.
4. Roncoroni L, Violi V, Montanari M, Muri M: Effect of somatostatin on
exocrine pancreas evaluated on a total external pancreatic fistula of
neoplastic origin. Am J Gastroenterol 1983, 78:425-8.
5. Wierup N, Svensson H, Mulder H, Sundler F: The ghrelin cell: a novel
developmentally regulated islet cell in the human pancreas. Regul Pept
2002, 107:63-9.
6. Dezaki K, Sone H, Yada T: Ghrelin attenuates glucose-induced insulin
release in an autocrine/paracrine manner in pancreatic islets.
Diabetologia 2006, 49:304-305.
7. Dezaki K, Sone H, Yada T: Ghrelin is a physiological regulator of insulin
release in pancreatic islets and glucose homeostasis. Pharmacology &
Therapeutics 2008, 118:239-249.
8. Herrera PL, Huarte J, Sanvito F, Meda P, Orci L, Vassalli JD: Embryogenesis
of the murine endocrine pancreas; early expression of pancreatic
polypeptide gene. Development 1991, 113:1257-65.
9. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA,
Hogan BL, Wright CV: PDX-1 is required for pancreatic outgrowth and
differentiation of the rostral duodenum. Development 1996, 122:983-95.
Kordowich et al. BMC Developmental Biology 2011, 11:52
http://www.biomedcentral.com/1471-213X/11/52
Page 15 of 16
10. Pictet RL, Clark WR, Williams RH, Rutter WJ: An ultrastructural analysis of
the developing embryonic pancreas. Dev Biol 1972, 29:436-67.
11. Teitelman G, Guz Y, Ivkovic S, Ehrlich M: Islet injury induces neurotrophin
expression in pancreatic cells and reactive gliosis of peri-islet Schwann
cells. J Neurobiol 1998, 34:304-18.
12. Upchurch BH, Aponte GW, Leiter AB: Expression of peptide YY in all four
islet cell types in the developing mouse pancreas suggests a common
peptide YY-producing progenitor. Development 1994, 120:245-52.
13. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, Sussel L: Ghrelin cells
replace insulin-producing beta cells in two mouse models of pancreas
development. Proc Natl Acad Sci USA 2004, 101:2924-9.
14. Miller K, Kim A, Kilimnik G, Jo J, Moka U, Periwal V, Hara M: Islet formation
during the neonatal development in mice. PLoS One 2009, 4:e7739.
15. Gu G, Brown JR, Melton DA: Direct lineage tracing reveals the ontogeny
of pancreatic cell fates during mouse embryogenesis. Mech Dev 2003,
120:35-43.
16. Jonsson J, Carlsson L, Edlund T, Edlund H: Insulin-promoter-factor 1 is
required for pancreas development in mice. Nature 1994, 371:606-9.
17. Serup P, Petersen HV, Pedersen EE, Edlund H, Leonard J, Petersen JS,
Larsson LI, Madsen OD: The homeodomain protein IPF-1/STF-1 is
expressed in a subset of islet cells and promotes rat insulin 1 gene
expression dependent on an intact E1 helix-loop-helix factor binding
site. Biochem J 1995, 310(Pt 3):997-1003.
18. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de
Angelis M, Lendahl U, Edlund H: Notch signalling controls pancreatic cell
differentiation. Nature 1999, 400:877-81.
19. Gradwohl G, Dierich A, LeMeur M, Guillemot F: neurogenin3 is required
for the development of the four endocrine cell lineages of the pancreas.
Proc Natl Acad Sci USA 2000, 97:1607-11.
20. Gu G, Dubauskaite J, Melton DA: Direct evidence for the pancreatic
lineage: NGN3+ cells are islet progenitors and are distinct from duct
progenitors. Development 2002, 129:2447-57.
21. Schwitzgebel VM, Scheel DW, Conners JR, Kalamaras J, Lee JE, Anderson DJ,
Sussel L, Johnson JD, German MS: Expression of neurogenin3 reveals an
islet cell precursor population in the pancreas. Development 2000,
127:3533-42.
22. Sussel L, Kalamaras J, Hartigan-O’Connor DJ, Meneses JJ, Pedersen RA,
Rubenstein JL, German MS: Mice lacking the homeodomain transcription
factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic
beta cells. Development 1998, 125:2213-21.
23. Sander M, Sussel L, Conners J, Scheel D, Kalamaras J, Cruz F Dela,
Schwitzgebel V, Hayes-Jordan A, German M: Homeobox gene Nkx6.1 lies
downstream of Nkx2.2 in the major pathway of beta-cell formation in
the pancreas. Development 2000, 127:5533-40.
24. St-Onge L, Sosa-Pineda B, Chowdhury K, Mansouri A, Gruss P: Pax6 is
required for differentiation of glucagon-producing alpha-cells in mouse
pancreas. Nature 1997, 387:406-9.
25. Heller RS, Stoffers DA, Liu A, Schedl A, Crenshaw EB, Madsen OD, Serup P:
The role of Brn4/Pou3f4 and Pax6 in forming the pancreatic glucagon
cell identity. Dev Biol 2004, 268:123-34.
26. Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P: The Pax4 gene is
essential for differentiation of insulin-producing beta cells in the
mammalian pancreas. Nature 1997, 386:399-402.
27. Collombat P, Mansouri A, Hecksher-Sorensen J, Serup P, Krull J, Gradwohl G,
Gruss P: Opposing actions of Arx and Pax4 in endocrine pancreas
development. Genes Dev 2003, 17:2591-603.
28. Jorgensen MC, Ahnfelt-Ronne J, Hald J, Madsen OD, Serup P, Hecksher-
Sorensen J: An illustrated review of early pancreas development in the
mouse. Endocr Rev 2007, 28:685-705.
29. Doyle MJ, Loomis ZL, Sussel L: Nkx2.2-repressor activity is sufficient to
specify alpha-cells and a small number of beta-cells in the pancreatic
islet. Development 2007, 134:515-23.
30. Doyle MJ, Sussel L: Nkx2.2 regulates beta-cell function in the mature
islet. Diabetes 2007, 56:1999-2007.
31. Schaffer AE, Freude KK, Nelson SB, Sander M: Nkx6 transcription factors
and Ptf1a function as antagonistic lineage determinants in multipotent
pancreatic progenitors. Dev Cell 2010, 18:1022-9.
32. Sander M, Neubuser A, Kalamaras J, Ee HC, Martin GR, German MS: Genetic
analysis reveals that PAX6 is required for normal transcription of
pancreatic hormone genes and islet development. Genes Dev 1997,
11:1662-73.
33. Wang Q, Elghazi L, Martin S, Martins I, Srinivasan RS, Geng X, Sleeman M,
Collombat P, Houghton J, Sosa-Pineda B: Ghrelin is a novel target of Pax4
in endocrine progenitors of the pancreas and duodenum. Dev Dyn 2008,
237:51-61.
34. Greenwood AL, Li S, Jones K, Melton DA: Notch signaling reveals
developmental plasticity of Pax4(+) pancreatic endocrine progenitors
and shunts them to a duct fate. Mech Dev 2007, 124:97-107.
35. Collombat P, Xu X, Ravassard P, Sosa-Pineda B, Dussaud S, Billestrup N,
Madsen OD, Serup P, Heimberg H, Mansouri A: The ectopic expression of
Pax4 in the mouse pancreas converts progenitor cells into alpha and
subsequently beta cells. Cell 2009, 138:449-62.
36. Collombat P, Hecksher-Sorensen J, Broccoli V, Krull J, Ponte I, Mundiger T,
Smith J, Gruss P, Serup P, Mansouri A: The simultaneous loss of Arx and
Pax4 genes promotes a somatostatin-producing cell fate specification at
the expense of the alpha- and beta-cell lineages in the mouse
endocrine pancreas. Development 2005, 132:2969-80.
37. Collombat P, Hecksher-Sorensen J, Krull J, Berger J, Riedel D, Herrera PL,
Serup P, Mansouri A: Embryonic endocrine pancreas and mature beta
cells acquire alpha and PP cell phenotypes upon Arx misexpression. J
Clin Invest 2007, 117:961-70.
38. Chao CS, Loomis ZL, Lee JE, Sussel L: Genetic identification of a novel
NeuroD1 function in the early differentiation of islet alpha, PP and
epsilon cells. Dev Biol 2007, 312:523-32.
39. Wang J, Elghazi L, Parker SE, Kizilocak H, Asano M, Sussel L, Sosa-Pineda B:
The concerted activities of Pax4 and Nkx2.2 are essential to initiate
pancreatic beta-cell differentiation. Dev Biol 2004, 266:178-89.
40. Gosmain Y, Marthinet E, Cheyssac C, Guerardel A, Mamin A, Katz LS,
Bouzakri K, Philippe J: Pax6 controls the expression of critical genes
involved in pancreatic {alpha} cell differentiation and function. J Biol
Chem 2010, 285:33381-93.
41. Katz LS, Gosmain Y, Marthinet E, Philippe J: Pax6 regulates the
proglucagon processing enzyme PC2 and its chaperone 7B2. Mol Cell
Biol 2009, 29:2322-34.
42. Nishimura W, Rowan S, Salameh T, Maas RL, Bonner-Weir S, Sell SM,
Sharma A: Preferential reduction of beta cells derived from Pax6-MafB
pathway in MafB deficient mice. Dev Biol 2008, 314:443-56.
43. Ahlgren U, Jonsson J, Edlund H: The morphogenesis of the pancreatic
mesenchyme is uncoupled from that of the pancreatic epithelium in
IPF1/PDX1-deficient mice. Development 1996, 122:1409-16.
44. Ohlsson H, Karlsson K, Edlund T: IPF1, a homeodomain-containing
transactivator of the insulin gene. Embo J 1993, 12:4251-9.
45. Miller CP, McGehee RE Jr, Habener JF: IDX-1: a new homeodomain
transcription factor expressed in rat pancreatic islets and duodenum
that transactivates the somatostatin gene. Embo J 1994, 13:1145-56.
46. Lynn FC, Smith SB, Wilson ME, Yang KY, Nekrep N, German MS: Sox9
coordinates a transcriptional network in pancreatic progenitor cells. Proc
Natl Acad Sci USA 2007, 104:10500-5.
47. Seymour PA, Freude KK, Tran MN, Mayes EE, Jensen J, Kist R, Scherer G,
Sander M: SOX9 is required for maintenance of the pancreatic
progenitor cell pool. Proc Natl Acad Sci USA 2007, 104:1865-70.
48. Hill JT, Chao CS, Anderson KR, Kaufman F, Johnson CW, Sussel L: Nkx2.2
activates the ghrelin promoter in pancreatic islet cells. Mol Endocrinol
2010, 24:381-90.
49. Andersen FG, Heller RS, Petersen HV, Jensen J, Madsen OD, Serup P: Pax6
and Cdx2/3 form a functional complex on the rat glucagon gene
promoter G1-element. FEBS Lett 1999, 445:306-10.
doi:10.1186/1471-213X-11-52
Cite this article as: Kordowich et al.: Arx and Nkx2.2 compound
deficiency redirects pancreatic alpha- and beta-cell differentiation to a
somatostatin/ghrelin co-expressing cell lineage. BMC Developmental
Biology 2011 11:52.
Kordowich et al. BMC Developmental Biology 2011, 11:52
http://www.biomedcentral.com/1471-213X/11/52
Page 16 of 16
